Nazanin Akbari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nazanin Akbari has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Zeynab Bayat
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran
3 shared publications - Maria Beihaghi
College of Agriculture, Ferdowsi University of Mashhad
2 shared publications Ali Qasemi
Department of Biology, Faculty of Sciences, University of Sistan and Baluchestan, Iran
1 shared publicationAli Salehinasab
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran
1 shared publicationAmin Mansoori
Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication- Daryoush Babazadeh
School of Veterinary Medicine, Shiraz University, Shiraz, Iran
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (5) , e70157
Exploring Uric Acid to HDL Ratio as a Long‐Term Biomarker for Diabetes Mellitus
Background: Diabetes mellitus (DM) poses a major challenge to public health worldwide. The ratio of serum uric acid to high‐density lipoprotein cholesterol (UHR) has recently emerged as a promising indicator of inflammation linked to a range of cardio‐metabolic conditions. However, its association with DM is not fully clear. Methods: Data from 7617 individuals aged 35–65 enrolled in the Mashhad stroke and heart atherosclerotic disorder (MASHAD) cohort were followed for a decade to explore the link between UHR and diabetes onset. Logistic regression, adjusted for confounders, evaluated the association. Restricted cubic spline models captured nonlinear trends, while receiver operating characteristic (ROC) analysis identified gender‐specific thresholds. All statistical procedures were performed using SPSS (v26). Results: Elevated levels of the UHR were significantly linked to a higher risk of developing DM. In the fully adjusted model, each incremental rise in UHR was associated with an odds ratio (OR) of 1.07 (95% CI [1.05–1.08], p < 0.001). Subgroup analyses also indicated consistent predictive capability across genders, and ROC analysis revealed optimal UHR thresholds of 12.74 for men (sensitivity 72.17%, specificity 47.79%, area under the curve (AUC) 0.6188) and 9.88 for women (sensitivity 59.46%, specificity 61.61%, AUC 0.6357). Conclusion: The UHR is a remarkable predictor of DM incidence over a decade‐long follow‐up, highlighting its potential as an early biomarker for diabetes risk assessment in clinical settings. Additional studies are needed to clarify the biological pathways linking UHR to diabetes development and to assess whether modifying this ratio could help lower disease risk.
- 13 February 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (5) , e70157
Open AccessExploring Uric Acid to HDL Ratio as a Long‐Term Biomarker for Diabetes Mellitus
Background: Diabetes mellitus (DM) poses a major challenge to public health worldwide. The ratio of serum uric acid to high‐density lipoprotein cholesterol (UHR) has recently emerged as a promising indicator of inflammation linked to a range of cardio‐metabolic conditions. However, its association with DM is not fully clear. Methods: Data from 7617 individuals aged 35–65 enrolled in the Mashhad stroke and heart atherosclerotic disorder (MASHAD) cohort were followed for a decade to explore the link between UHR and diabetes onset. Logistic regression, adjusted for confounders, evaluated the association. Restricted cubic spline models captured nonlinear trends, while receiver operating characteristic (ROC) analysis identified gender‐specific thresholds. All statistical procedures were performed using SPSS (v26). Results: Elevated levels of the UHR were significantly linked to a higher risk of developing DM. In the fully adjusted model, each incremental rise in UHR was associated with an odds ratio (OR) of 1.07 (95% CI [1.05–1.08], p < 0.001). Subgroup analyses also indicated consistent predictive capability across genders, and ROC analysis revealed optimal UHR thresholds of 12.74 for men (sensitivity 72.17%, specificity 47.79%, area under the curve (AUC) 0.6188) and 9.88 for women (sensitivity 59.46%, specificity 61.61%, AUC 0.6357). Conclusion: The UHR is a remarkable predictor of DM incidence over a decade‐long follow‐up, highlighting its potential as an early biomarker for diabetes risk assessment in clinical settings. Additional studies are needed to clarify the biological pathways linking UHR to diabetes development and to assess whether modifying this ratio could help lower disease risk.
- Open Access
- 25 December 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (2) , 36-42
Bacterial Resistance of Acinetobacter baumannii: A Global Concern
Acinetobacter baumannii (A. baumannii), one of the five most important bacteria with global threat to human health due to constantly increasing resistance (ESKAPE organisms), identified as a enormous threat in healthcare facilities, can create antibiotic resistance. The implementation of early detection and identification of multidrug-resistant A. baumannii is serious to control its spread. The this study presents the human infection of A. baumannii, pathological findings, virulence factors of A. baumannii, antibiotic resistance mechanisms, and the therapeutic options available for treating A. baumannii infections. The ability of A. baumannii to develop antibiotic resistance mechanisms allows the organism to prosper in hospital settings, facilitating the global spread of multidrug-resistant strains. To dominate this problem, knowledge of the pathogenesis and antibiotic resistance mechanisms of A. baumannii is important. As reported, A. baumannii resistance to aminoglycosides, fluoroquinolones, and carbapenems increased, and resistance to lipopeptides, such as polymyxin B and colistin, are lower compared to that of other antimicrobial drugs. Therefore, novel prevention and treatment strategies against A. baumannii infections are warranted.
- 25 December 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (2) , 36-42
Open AccessBacterial Resistance of Acinetobacter baumannii: A Global Concern
Acinetobacter baumannii (A. baumannii), one of the five most important bacteria with global threat to human health due to constantly increasing resistance (ESKAPE organisms), identified as a enormous threat in healthcare facilities, can create antibiotic resistance. The implementation of early detection and identification of multidrug-resistant A. baumannii is serious to control its spread. The this study presents the human infection of A. baumannii, pathological findings, virulence factors of A. baumannii, antibiotic resistance mechanisms, and the therapeutic options available for treating A. baumannii infections. The ability of A. baumannii to develop antibiotic resistance mechanisms allows the organism to prosper in hospital settings, facilitating the global spread of multidrug-resistant strains. To dominate this problem, knowledge of the pathogenesis and antibiotic resistance mechanisms of A. baumannii is important. As reported, A. baumannii resistance to aminoglycosides, fluoroquinolones, and carbapenems increased, and resistance to lipopeptides, such as polymyxin B and colistin, are lower compared to that of other antimicrobial drugs. Therefore, novel prevention and treatment strategies against A. baumannii infections are warranted.
- Open Access
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 1-5
Screening of Biosurfactant-producing Bacteria from Symbiotic Microbes with Gastropods in the Persian Gulf
Introduction: Biosurfactants or surface-active compounds with amphiphilic molecular structures, including a hydrophilic and a hydrophobic domain, are produced by microorganisms. These compounds increase the biodegradation of hydrocarbons in the environment due to their ability to emulsify hydrocarbon-water mixtures. This study was conducted to isolate and characterize biosurfactant-producing bacteria from the samples of Gastropods. Materials and Methods: The gastropod samples were collected from oil-contaminated sites in the Persian Gulf, Middle East. Biosurfactant-producing strains were isolated from these samples. The biosurfactant production ability was analyzed using Drop Collapse TEST, oil spreading test, emulsification activity test, and BATH test. Results: In total, 11 biosurfactant-producing strains were isolated. Two isolates with higher growth rates and biosurfactant production ability were selected for further studies. The best isolates were identified as Halomonas sp. isolate BHA16 and Vibrio alginolyticus isolate BHA 17 based on molecular analysis. Gas chromatography analysis of remaining crude oil confirmed that these strains could degrade to 51.44 % and 67.58% of crude oil, respectively. Conclusion: The results of this study indicated the surfactant activity of the bacterial strains isolated from Gastro pods had a good potential for the biodegradation of crude oil and could be used for the cleanup of oil-contaminated marine environments.
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 1-5
Open AccessScreening of Biosurfactant-producing Bacteria from Symbiotic Microbes with Gastropods in the Persian Gulf
Introduction: Biosurfactants or surface-active compounds with amphiphilic molecular structures, including a hydrophilic and a hydrophobic domain, are produced by microorganisms. These compounds increase the biodegradation of hydrocarbons in the environment due to their ability to emulsify hydrocarbon-water mixtures. This study was conducted to isolate and characterize biosurfactant-producing bacteria from the samples of Gastropods. Materials and Methods: The gastropod samples were collected from oil-contaminated sites in the Persian Gulf, Middle East. Biosurfactant-producing strains were isolated from these samples. The biosurfactant production ability was analyzed using Drop Collapse TEST, oil spreading test, emulsification activity test, and BATH test. Results: In total, 11 biosurfactant-producing strains were isolated. Two isolates with higher growth rates and biosurfactant production ability were selected for further studies. The best isolates were identified as Halomonas sp. isolate BHA16 and Vibrio alginolyticus isolate BHA 17 based on molecular analysis. Gas chromatography analysis of remaining crude oil confirmed that these strains could degrade to 51.44 % and 67.58% of crude oil, respectively. Conclusion: The results of this study indicated the surfactant activity of the bacterial strains isolated from Gastro pods had a good potential for the biodegradation of crude oil and could be used for the cleanup of oil-contaminated marine environments.
- Open Access
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 28-35
A Summary of Autophagy Mechanisms in Cancer Cells
Autophagy is a well-known vital process in cells and plays a significant role in biological evolution, the immune system, and cell death. It can be effective in fatal disorders, such as nervous system degeneration, autoimmune diseases, and cancer. Autophagy has a dual role; on the one hand, it increases cell survival, and on the other hand, it causes cell death in advanced stages although no agreement has yet been accomplished on the role of autophagy in cellular processes. There is evidence that autophagic signaling regulation is inversely related to oncogenic signaling. Numerous commonly activated oncogenes (class I PtdIns3K, Akt, TOR, Bcl-2) inhibit autophagy, while commonly mutated or epigenetically silenced tumor suppressor genes (p53, PTEN, TSC1/TSC2) promote autophagy. Autophagy promotes cancer progression by supplying sufficient nutrients that enable cancer cell growth. FIP200, a related- autophagy protein, interacts with ATG 13 and induces autophagy. Increased autophagy causes the interaction of Becklin 118 with HER2, resulting in an increase in tumorigenesis. In order to make complete use of the autophagic properties in cancer treatment, further studies on its role in disease in the different biologics fields are essential. Cancer stem cells (CSCs) can regenerate, cause cancer, and enhance resistance to treatment, metastasis, and recurrence. Autophagy moderates stressful conditions and promotes resistance to anticancer therapy. In addition, autophagy regulates the ability of radiation in CSCs and leads to failure in anticancer therapies. Hence, autophagy is a potential therapeutic target for metastasis resistance and anticancer therapy recurrence. Regulation of autophagy using autophagy modulators alone does not improve the therapeutic effects of anticancer reagents. In contrast, it has supplied nutrients for cancer cells. Consequently, clinical trials aiming for autophagy through a combination of autophagy modulations and anticancer reagents are crucial to consider autophagy as a potentially effective therapeutic strategy in anticancer therapy.
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 28-35
Open AccessA Summary of Autophagy Mechanisms in Cancer Cells
Autophagy is a well-known vital process in cells and plays a significant role in biological evolution, the immune system, and cell death. It can be effective in fatal disorders, such as nervous system degeneration, autoimmune diseases, and cancer. Autophagy has a dual role; on the one hand, it increases cell survival, and on the other hand, it causes cell death in advanced stages although no agreement has yet been accomplished on the role of autophagy in cellular processes. There is evidence that autophagic signaling regulation is inversely related to oncogenic signaling. Numerous commonly activated oncogenes (class I PtdIns3K, Akt, TOR, Bcl-2) inhibit autophagy, while commonly mutated or epigenetically silenced tumor suppressor genes (p53, PTEN, TSC1/TSC2) promote autophagy. Autophagy promotes cancer progression by supplying sufficient nutrients that enable cancer cell growth. FIP200, a related- autophagy protein, interacts with ATG 13 and induces autophagy. Increased autophagy causes the interaction of Becklin 118 with HER2, resulting in an increase in tumorigenesis. In order to make complete use of the autophagic properties in cancer treatment, further studies on its role in disease in the different biologics fields are essential. Cancer stem cells (CSCs) can regenerate, cause cancer, and enhance resistance to treatment, metastasis, and recurrence. Autophagy moderates stressful conditions and promotes resistance to anticancer therapy. In addition, autophagy regulates the ability of radiation in CSCs and leads to failure in anticancer therapies. Hence, autophagy is a potential therapeutic target for metastasis resistance and anticancer therapy recurrence. Regulation of autophagy using autophagy modulators alone does not improve the therapeutic effects of anticancer reagents. In contrast, it has supplied nutrients for cancer cells. Consequently, clinical trials aiming for autophagy through a combination of autophagy modulations and anticancer reagents are crucial to consider autophagy as a potentially effective therapeutic strategy in anticancer therapy.
- Open Access
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 16-22
In Silico Analyzes for the Inhibition of HIV Protease by Ritonavir and Indinavir
Introduction: This research was conducted to investigate the molecular interaction of HIV protease inhibitor drugs using molecular docking. HIV protease is responsible for processing gag and gag-polyproteins during virion maturation. The activity of this enzyme is essential against viral infections and has beneficial therapeutic effects on HIV treatment. Materials and Methods: To meet the aim of the study, indinavir and ritonavir were selected as HIV Protease inhibitor drugs. The necessary information on molecular docking was collected through information servers, such as Drug bank and Program database (PDB). Then, molecular docking was performed using Molegro virtual docker software. In order to check the stability of the resulting complex structure and its cellular penetration, a molecular dynamics simulation was run for 50 nanoseconds using GROMACS2019.6 package and Amber99SB force force field. During the molecular dynamics simulation, root mean square deviations (RMSD), root mean square fluctuations (RMSF), the radius of gyration (RG), hydrogen bonds, and distance between ligands and complex were investigated. Results: The obtained results indicated that the RMSD of the complex of the ligands and HIV protease at the end of 50 nanoseconds had a linear slope. Hydrogen bonds decreased at beginning of simulation but they increase at the end of simulation However RG was decreased at the end of the simulation Also the RMSF was decreased at the end of simulation rather than beginning of simulation, So all the obtained results showing the stability and strength of the structure. Conclusion: Molecular docking method can indicate the relationship between structure-activity and the effectiveness of ligands on HIV protease based on the level of interaction between the ligands and the receptors.
- 1 September 2022
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 1 (1) , 16-22
Open AccessIn Silico Analyzes for the Inhibition of HIV Protease by Ritonavir and Indinavir
Introduction: This research was conducted to investigate the molecular interaction of HIV protease inhibitor drugs using molecular docking. HIV protease is responsible for processing gag and gag-polyproteins during virion maturation. The activity of this enzyme is essential against viral infections and has beneficial therapeutic effects on HIV treatment. Materials and Methods: To meet the aim of the study, indinavir and ritonavir were selected as HIV Protease inhibitor drugs. The necessary information on molecular docking was collected through information servers, such as Drug bank and Program database (PDB). Then, molecular docking was performed using Molegro virtual docker software. In order to check the stability of the resulting complex structure and its cellular penetration, a molecular dynamics simulation was run for 50 nanoseconds using GROMACS2019.6 package and Amber99SB force force field. During the molecular dynamics simulation, root mean square deviations (RMSD), root mean square fluctuations (RMSF), the radius of gyration (RG), hydrogen bonds, and distance between ligands and complex were investigated. Results: The obtained results indicated that the RMSD of the complex of the ligands and HIV protease at the end of 50 nanoseconds had a linear slope. Hydrogen bonds decreased at beginning of simulation but they increase at the end of simulation However RG was decreased at the end of the simulation Also the RMSF was decreased at the end of simulation rather than beginning of simulation, So all the obtained results showing the stability and strength of the structure. Conclusion: Molecular docking method can indicate the relationship between structure-activity and the effectiveness of ligands on HIV protease based on the level of interaction between the ligands and the receptors.